Jacobs Levy Equity Management
RAIN

Jacobs Levy Equity Management’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Jacobs Levy Equity Management’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,635
Closed -$110K – 1063
2022
Q3 		$110K Buy
+22,635
New +$142K ﹤0.01% 957

Other funds holding RAIN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jacobs Levy Equity Management's RAIN Position: Q4 2022 in Review

Jacobs Levy Equity Management sold out of Rain Oncology Inc. Common Stock (RAIN) in Q4 2022, closing a stake of 22,635 shares — an estimated $110K sold.

Jacobs Levy Equity Management first reported a position in RAIN in Q3 2022 and held it in 1 quarter. The position peaked at $110K in Q3 2022. 46 funds tracked by Wall St. Rank hold RAIN as of Q4 2022.

  • Jacobs Levy Equity Management reported no remaining Rain Oncology Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 22,635 Rain Oncology Inc. Common Stock shares in Q4 2022, an estimated $110K.
  • Jacobs Levy Equity Management first reported a position in Rain Oncology Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Rain Oncology Inc. Common Stock position peaked at $110K in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q4 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.